Galenica Sante AG/ CH0360674466 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 3.98 bill.EUR | - | - |
GlobeNewswire
11/28/2016
FDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-D...
GlobeNewswire
11/28/2016
FDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-D...
GlobeNewswire
10/6/2016
Appointments at the Galenica Group: New management at Vifor Pharma and new Galenica Group CFO desig...
GlobeNewswire
9/2/2016
Galenica completes acquisition of Relypsa, strengthening Vifor Pharma's position in cardio-renal the...
GlobeNewswire
9/1/2016
Galenica announces Expiration of Cash Tender Offer for Shares of Common Stock of Relypsa